Skip to main content
All lobbying filings

Elite Strategic Services

Elite Strategic Services filed a Q2 report for Conservatives for Property Rights on July 1, 2025, reporting $15,000 in lobbying income.

Lobbying for Conservatives for Property Rights · Coalition

As filed: ELITE STRATEGIC SERVICES for CONSERVATIVES FOR PROPERTY RIGHTS.

All filings by Elite Strategic Services · Everything Conservatives for Property Rights has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 1, 2025
Income
$15,000
What the client paid this registrant for the period.
Client based in
South Carolina

Official filing document

 Lobbyists on this filing 1
  • JAMES R EDWARDS JR
    Previously held: LD, Rep. Ed Bryant; LA/Press Secretary, Rep. John Duncan; Special Assistant, Senate Judiciary Committee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 7

S. 708/H.R. 1574 (RESTORE Patent Rights Act) S. 1553/H.R. 3160 (Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act) S. 1546/H.R. 3152 (Patent Eligibility Restoration Act (PERA)) S. 1367/H.R. 2794 (NO FAKES Act) S. 1041 (Affordable Prescriptions for Patients Act) S. 1097 (Interagency Patent Coordination and Improvement Act) Comment on the World Intellectual Property Organization Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (Docket No. PTO-C-2024-0048) Advancing Americas Interest Act to disadvantageously change U.S. innovator firms access to and treatment before the U.S. International Trade Commission when seeking Section 337 remedies blocking importation of U.S. patent-infringing goods Candidates and nominations for Patent & Trademark Office leadership positions and Patent Public Advisory Committee America First Trade Policy section (3)(e) China intellectual property policies Abuse of section 1498 as drug price controls to expropriate patent rights Abuse of the Inter Partes Review (IPR) process by the Patent Trial & Appeal Boards allowing cases to proceed per the egregious application of the repudiated compelling merits standard for PTAB institution

S. 832/H.R. 1492 (Ensuring Pathways to Innovative Cures (EPIC) Act) Pharmacy benefits management reform Inflation Reduction Act drug price negotiation timing H.R. 1 (One Big Beautiful Bill Act) provisions related to proposed government drug price controls known as most favored nation being added to the Medicaid program H.R. 1 (One Big Beautiful Bill Act) provisions related to Health Savings Account (HSA) reforms Centers for Medicare & Medicaid Services (CMS) Request for Comments on Medicare Drug Price Negotiation Program Draft Guidance, FR Doc. 2025-08607

H.R. 384 (One Agency Act) S. 1040 (Drug Competition Enhancement Act) S. 1096 (Preserve Access to Affordable Generics and Biosimilars Act)

S. 587/H.R. 1301 (Death Tax Repeal Act) Reauthorization and making permanent key Tax Cuts and Jobs Act (TCJA) tax policies, i.e., corporate tax rates, progrowth tax incentive provisions H.R. 2230 (Independent Programmers Tax Incentive Act)

Executive Order 14192, Unleashing Prosperity Through Deregulation H. Res. 294 provisions related to proxy voting

Special 301 Report - bolstering U.S. advocacy abroad for respecting intellectual property rights U.S. Trade Representative Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation (Docket No. USTR-2025-0011)

H. J. Res. 88, revoking pursuant to the Congressional Review Act California waivers from the Clean Air Act Reform of the definition of the Waters of the United States (WOTUS) under the Clean Water Act

 Bills named in this filing 21
  • S. 708
    RESTORE Patent Rights Act of 2025
  • H.R. 1574
    RESTORE Patent Rights Act of 2025
  • S. 1553
    PREVAIL Act
  • H.R. 3160
    PREVAIL Act
  • S. 1546
    Patent Eligibility Restoration Act of 2025
  • H.R. 3152
    Patent Eligibility Restoration Act of 2025
  • S. 1367
    NO FAKES Act of 2025
  • H.R. 2794
    NO FAKES Act of 2025
  • S. 1041
    Affordable Prescriptions for Patients Act
  • S. 1097
    Interagency Patent Coordination and Improvement Act of 2025
  • S. 832
    EPIC Act of 2025
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 384
    One Agency Act
  • S. 1040
    Drug Competition Enhancement Act
  • S. 1096
    Preserve Access to Affordable Generics and Biosimilars Act
  • S. 587
    Death Tax Repeal Act of 2025
  • H.R. 1301
    Death Tax Repeal Act
  • H.R. 2230
    Independent Programmers Tax Incentive Act
  • H. Res. 294
    Providing for consideration of the joint resolution (S.J. Res. 18) disapproving the rule submitted by the Bureau of Con…
  • H.J. Res. 88
    Providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Enviro…

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem